RBC Capital slightly trimmed Vertex Pharmaceuticals’ price target from $423 to $420, but the firm’s rating stayed the course.

Factory Mutual Insurance Co. dramatically upped its stake in Regeneron Pharmaceuticals by 210.3%, acquiring an additional ...

NorthCrest Asset Management took a modest $285K stake in Marsh & McLennan Companies, joining a parade of hedge funds piling ...

SG Americas Securities increased its stake in Deere & Company by 42.3%, grabbing 1,735 more shares worth roughly $2.74 ...

Hennessy Advisors brewed up a stronger position in Starbucks, upping their stake by 8.3% in the first quarter. The firm now ...

Airbnb is in analyst limbo, with 36 firms collectively giving it a “Hold” rating—Wall Street’s version of a shrug. Five ...

Stock Yards Bank & Trust Co. trimmed its CVS Health stake by 17.1% in Q1, selling 5,409 shares and retaining 26,239 shares ...

KLA just got a market makeover thanks to Oppenheimer’s analyst Edward Yang, who jacked up the stock's price target from $740 ...

Boston Scientific just scored a clean bill of health from analysts, with Leerink Partners launching coverage and slapping on ...

Bristol Myers Squibb has declared a quarterly dividend of $0.62 per share, maintaining its impressive 55-year streak of ...

Palantir Technologies ended the day down 2.24%, underperforming the broader market in what looked like a synchronized stumble ...

Dynamic Advisor Solutions raised its Lockheed Martin holdings by 5.4%, joining a parade of major investors boosting their ...